Introduction
============

Metagenomic studies on samples from a range of different environments and the potential of bacteriophage (phage) therapy to treat antibiotic-resistant, clinically relevant bacteria have renewed interest in virus-like particles (VLPs). Metagenomic (virome) studies, in particular, have demonstrated that VLPs are the most genetically diverse entities in the biosphere ([@ref-43]). Given their staggering abundance and diversity, coupled to their perceived crucial role in the functioning of ecosystems, it is surprising that VLPs (and by extension, phages) remain the most poorly characterized biological entities ([@ref-43]).

Virome and classical studies examining VLPs in the faeces of adults and infants have demonstrated that there is a vast diversity and abundance of phages associated with the human gut microbiota ([@ref-5]; [@ref-4]; [@ref-27]; [@ref-42]; [@ref-23]; [@ref-35]; [@ref-58]; [@ref-17]). Similar to the prokaryotic make-up of the human gut microbiota, each individual harbours a unique virome (dsDNA, ssDNA, RNA) that is temporally stable, and whose composition appears to be influenced by diet ([@ref-42]; [@ref-35]; [@ref-34]). [@ref-27] reported that mucosal biopsies taken from healthy individuals and Crohn's patients contained between 4.4 × 10^7^ and 1.7 × 10^10^ (mean 1.2 × 10^9^) VLPs/biopsy, with Crohn's patients harbouring significantly more VLPs in their biopsies than healthy individuals. A recent study in which phage populations in human faecal and caecal-effluent samples were estimated using epifluorescence microscopy (EFM) and transmission electron microscopy (TEM) reported the presence of up to 10^12^ VLPs/g faeces (EFM) and at least 1 × 10^5^ VLPs/ml caecal effluent (TEM) ([@ref-17]). However, little is known about the host ranges of these VLPs, and their abundance within other regions of the gastrointestinal tract.

Generation of comprehensive gut virome data has been hampered by the lack of available methods for concentrating VLPs within faecal samples and extracting sufficient amounts of DNA from them so sequencing can be performed without the need to amplify the template DNA ([@ref-43]). However, the recent publication of a PEGylation method applied to human faecal samples and demonstration that microgram quantities of DNA can be isolated from faecal VLPs has gone some way to overcome this substantial technical hurdle ([@ref-17]). When it comes to annotation of virome sequence data, a major stumbling block is the lack of available phage genome sequences against which contigs can be compared, plus the large number of viral genes that are currently not represented in sequence databases. For example, studies of the human faecal virome have reported that between 66% and 98% of the generated sequences have no significant hits with GenBank sequences ([@ref-4]; [@ref-42]; [@ref-35]). There are few, if any, available sequences for human-gut-associated lytic phages so there is a need to isolate and genomically characterize phages from gastrointestinal sources, rather than relying on the assumption that phages found in sewage are primarily of human gut origin. However, sequences of (predicted) prophages from genome sequences of bifidobacteria, lactobacilli, *Helicobacter pylori* and *Escherichia coli* (strain Nissle 1917) of gastrointestinal origin are available ([@ref-54]; [@ref-56]; [@ref-53]; [@ref-31]).

During a study of the microbiota associated with the caecum of patients with Irritable Bowel Syndrome and healthy controls, attempts were made to isolate bacterium--phage combinations from samples of caecal effluent. Herein, we report the isolation and characterization of a *Klebsiella pneumoniae* subsp. *pneumoniae*--phage combination from the caecal effluent of a healthy woman, and the implications of our findings in relation to gastrointestinal microbial ecology and the potential of the human gut as a source of phages with therapeutic uses. Previous studies describing the isolation of lytic phages against *K. pneumoniae* have reported recovery of these entities from wastewater, seawater, sewage and sewage-contaminated water samples, but never directly from gastrointestinal contents ([@ref-51]; [@ref-24]; [@ref-25]; [@ref-12]; [@ref-19]; [@ref-11]; [@ref-18]; [@ref-21]; [@ref-20]).

Materials and Methods
=====================

Ethical approval and patient information
----------------------------------------

Ethical approval to collect caecal effluent from patients was obtained from St Thomas' Hospital Research Ethics Committee (06/Q0702/74) covering Guy's and St Thomas' Hospitals, and transferred by agreement to London Bridge Hospital. Patients provided written consent to provide samples. The caecal effluent was collected as described by [@ref-17] from a 31-year-old female who showed no evidence of colonic abnormalities or disease as based on a routine colonoscopic examination.

Sample processing, and isolation of bacteria and phages from caecal effluent
----------------------------------------------------------------------------

The sample was transported to the University of Reading under anaerobic conditions (in a gas jar with an anaerobic gas-generating pack; Oxoid Ltd, Hampshire, UK) and on ice, where it was processed within 3 h of collection. The sample was transferred to an anaerobic cabinet (Whitley MG1000 anaerobic workstation; DW Scientific, West Yorkshire, UK; gas composition 80% N~2~, 10% H~2~, 10% CO~2~) and mixed well by shaking. An aliquot (1 ml) of the sample was diluted with 9 ml sterile, anaerobic half-strength peptone water (Oxoid) in a sterile universal bottle containing 2-mm glass beads. A dilution series (10^−1^ to 10^−6^) was prepared from the homogenate in sterile, anaerobic half-strength peptone water (Oxoid). Aliquots (20 µl) were plated in triplicate onto fastidious anaerobic agar (BIOTEC laboratories, Ipswich, UK) containing 5% laked horse blood. Bacteria were incubated anaerobically for 5 days at 37 °C, and then enumerated. Ten colonies were selected randomly, streaked to purity, and stored on Microbank cryogenic beads (Prolab Diagnostics, Merseyside, UK) at −70 °C.

The remaining neat caecal effluent (∼25 ml) was processed as described by [@ref-17]. Briefly, the sample was diluted 1:4 (v/v) with sterile TBT buffer (100 mM Tris/HCl, pH 8.0; 100 mM NaCl; 10 mM MgCl~2~⋅6H~2~O filtered through a 0.1 mm pore size filter prior to autoclaving). The sample was homogenized in a stomacher (Stomacher 400 Lab System; Seward, West Sussex, UK) for 2 min at 'high' speed, and then placed on ice for 2 h to allow detachment of phages from and settlement of particulate material. The homogenate was centrifuged at 11,180 ***g*** for 30 min at 4 °C, and the supernatant passed through a sterile 0.45 µm cellulose acetate filter (Millipore, Billerica, Massachusetts, USA). The filtrate was stored at 4 °C until used in spot assays.

Identification of isolated bacteria
-----------------------------------

DNA was isolated from bacteria using InstaGene Matrix (Bio-Rad, Deeside, UK) according to the manufacturer's instructions. Partial (∼600 nt) 16S rRNA gene sequences were obtained for the isolates via the University of Reading's Biocentre. Nearest relatives of isolates were determined using EzTaxon ([@ref-10]). The identity of strain L4-FAA5, tentatively identified as *Klebsiella pneumoniae* on the basis of its 16S rRNA gene sequence, was confirmed using a species-specific PCR that detects the 16S--23S internal transcribed spacer unit of *K. pneumoniae* as well as capsular-type-specific, and virulence gene targets ([@ref-52]). Malonate and Voges--Proskauer reactions were positive indicating that the isolate was subsp. *pneumoniae* (rather than subsp. *ozaenae*) ([@ref-52]). Typing was carried out by VNTR analysis at loci A, E, H, J, K and D ([@ref-52]) and an additional three loci (N1, N2 and N4). Primers, repeat sizes and flanking sequence sizes for the additional loci were: N1F 5'-CATCAGGTGCAAGATTCCA-3' and N1R 5'- TGAGCGATTGCTGGCCTA-3', 116 bp repeat with a 107 bp flanking sequence; N2F 5'-GATGCGGCAAGCACCAC-3' and N2R 5'-ACGCCCTGACCATTATGC-3', 57 bp repeat with a 109 bp flanking sequence; and N4F 5'-GTGCGGTGATTGTGATGG-3' and N4R 5'-CTGACAACGTCGATGTGG-3', 67 bp repeat with a 119 bp flanking sequence.

Screening of bacteria against filtered caecal effluent
------------------------------------------------------

*K. pneumoniae* strains isolated from the caecum were grown to OD~660~ ∼ 0.4 in tryptone soya broth (Oxoid Ltd), and used in spot assays as follows. An aliquot of culture (200 µl) was inoculated into 3 ml tryptone soya broth containing 0.3% (w/v) agarose (SeaKem LE agarose; Lonza Rockland) that had been heat-treated by microwaving and dispensed aseptically from a larger volume before cooling to 48 °C. The overlays containing bacteria were poured over 20 ml solid agar plates of autoclaved tryptone soya agar (Oxoid Ltd). Once the agar had solidified, a 10 µl spot of filtered caecal effluent was applied to the overlays, and the plates were incubated overnight at 37 °C in the anaerobic cabinet. Identical plaques were observed on all *K. pneumoniae* isolates; strain L4-FAA5 was used to propagate and purify an isolated phage in tryptone soya broth or reinforced clostridial and nutrient media (Oxoid Ltd). Neither calcium nor magnesium was added to media during propagations.

The ability of the purified phage to infect a panel of *K. pneumoniae* subsp. *pneumoniae* clinical isolates ([Table 1](#table-1){ref-type="table"}) was determined using the spot assay as described above, except that nutrient agar plates were used for the base. Strain L4-FAA5 was used as a positive control.
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###### Description of *K. pneumoniae* subsp. *pneumoniae* isolates against which phage KLPN1 was screened.

![](peerj-03-1061-g005)

  Strain[^a^](#table-1fn2){ref-type="fn"}   Capsular type (K PCR result)[^b^](#table-1fn3){ref-type="fn"}   *rmpA*   *wcaG*   Source                                                     Infected by phage KLPN1
  ----------------------------------------- --------------------------------------------------------------- -------- -------- ---------------------------------------------------------- --------------------------------------
  L4-FAA5                                   K2                                                              \+       --       Human caecal effluent                                      Yes
  K/5216                                    K1 (K1 cluster of CC23)                                         \+       \+       Liver abscess (Taiwan)                                     No
  NCTC 5055                                 K2 (reference strain)                                           \+       --       Human                                                      Yes[^d^](#table-1fn5){ref-type="fn"}
  NCTC 9660                                 K5 (reference strain)                                           --       --       Cloacae of horse                                           No
  PHE1                                      --                                                              --       --       Rectal swab                                                No
  PHE2                                      --                                                              --       --       Human clinical                                             No
  PHE3                                      --                                                              --       --       Sputum, transplant patient                                 No
  PHE4                                      --                                                              --       --       Urine, spinal injury patient                               No
  PHE5                                      --                                                              --       --       Human blood                                                No
  PHE6                                      --                                                              --       \+       Urine, incontinent patient                                 No
  PHE7                                      --                                                              --       --       Human clinical                                             No
  PHE8                                      --                                                              --       --       Human blood                                                No
  PHE9                                      --                                                              --       --       Human clinical                                             No
  PHE10                                     --                                                              --       --       Human blood                                                No
  PHE11[^c^](#table-1fn4){ref-type="fn"}    K2                                                              --       --       Blood, patient with urinary tract infection                Yes[^d^](#table-1fn5){ref-type="fn"}
  PHE12[^c^](#table-1fn4){ref-type="fn"}    K2                                                              --       --       Urine                                                      Yes[^d^](#table-1fn5){ref-type="fn"}
  PHE13                                     K2                                                              --       --       Blood and sputum, patient with bacteraemia and pneumonia   Yes[^d^](#table-1fn5){ref-type="fn"}
  PHE14                                     K2                                                              \+       --       Sputum, patient with bacteraemia                           Yes[^d^](#table-1fn5){ref-type="fn"}
  PHE15                                     K2                                                              --       --       Urine, cardiac patient                                     Yes[^d^](#table-1fn5){ref-type="fn"}
  PHE16                                     K20                                                             \+       --       Sputum, transplant patient                                 No
  PHE17                                     K54                                                             --       \+       Intensive care unit                                        No
  PHE18                                     K57                                                             --       --       Sputum, transplant patient                                 No

**Notes.**

ndNo data

Strains with the prefix PHE were submitted for typing by healthcare providers to Public Health England--Colindale. Each isolate represented a distinct strain, with the exception of isolates PHE11 and PHE12.

K PCR can detect K1, K2, K5, K20, K54 and K57 capsular types.

Corresponds to multi-locus sequence type ST14, often seen among multi-drug-resistant isolates producing carbapenemases.

Phage KLPN1 did not exhibit depolymerase activity on these K2 isolates, but it did on L4-FAA5.

Purification of phage particles
-------------------------------

A 100-ml culture of strain L4-FAA5 was grown to mid-exponential phase, inoculated with 100 µl of phage stock (∼10^10^ pfu/ml) and incubated until the medium became clear (∼2 h after infection). The lysate was centrifuged at 4,500 ***g*** for 10 min, then passed through a 0.45 µm cellulose acetate filter. PEG 8000 (10%, w/v) and NaCl (6%, w/v) were added to the filtrate, and mixed until all particulates had dissolved. The sample was left at 4 °C for 16 h, then centrifuged at 4,500 ***g*** for 30 min. The supernatant was removed and the pellet resuspended in 4 ml TBT buffer. A CsCl block gradient was formed with 5 M and 3 M CsCl, both prepared in TBT buffer and samples were placed on top of this gradient and subjected to centrifugation at 100,000 ***g*** for 2 h at 4 °C. The band containing ∼2 ml of TBT buffer and the phages was drawn out of the tube and the purified sample was transferred to dialysis tubing (4,000--6,000 Da cut-off), and dialysed against TBT buffer overnight. The TBT buffer was replaced with fresh TBT buffer, and the sample dialysed for a further 4 h. The purified phage particles were removed from the dialysis tubing and stored at 4 °C.

Transmission electron microscopy
--------------------------------

This was done as described by [@ref-17].

Extraction of DNA from phage KLPN1 and restriction enzyme profiles
------------------------------------------------------------------

An aliquot (250 µl) of the purified phage particle stock was treated with DNAse (2 U) for 30 min at 37 °C, then heated for 10 min at 80 °C. Two phenol/chloroform extractions were performed, before the DNA was precipitated using 1/10 volume of 3 M sodium acetate (pH 4.8) and 2 volumes of ice-cold ethanol. After air-drying, DNA was resuspended in 100 µl TE buffer. Restriction profiles were obtained for phage KLPN1 using the enzymes EcoRV and HaeIII (SuRE/Cut; Roche Applied Science, Basel, Switzerland): restriction digests contained 3 µl H~2~O, 1 µl enzyme, 1 µl enzyme buffer and 5 µl DNA, and were incubated for 3 h at 37 °C before being run on a 0.8% (w/v) agarose gel (1 h, 75 V) and stained with ethidium bromide.

Whole-genome sequencing and annotation of the phage genome
----------------------------------------------------------

DNA (5 µg) was extracted and concentration verified by Nanodrop quantification. Confirmatory molecular identification tests were also conducted on the DNA extract prior to shipment to the contract sequencing facility (Macrogen Inc., Seoul, Korea). Eighty-fold sequencing coverage was obtained using pyrosequencing technology on a 454 FLX instrument. The individual sequence files generated by the 454 FLX instrument were assembled with GSassembler (454 Lifesciences, Branford, Connecticut, USA) to generate a consensus sequence. To ensure correct assembly and resolve any remaining base-conflicts, short segments of the genome were amplified by PCR and the generated amplicons were then subjected to Sanger sequencing (MWG, Ebersberg, Germany). Open reading frames (ORFs) were automatically predicted using Genemark ([@ref-2]). General feature format (gff) files were generated for the predicted phage proteome (retaining proteins with a minimum size of 30 amino acids) and visualized using the annotation software Artemis v10.0 ([@ref-46]). ORF boundaries were verified and, where required, adjusted by manual inspection of Shine--Delgarno sequences. BLASTP ([@ref-1]) was used to provide preliminary functional annotation data, and to carry out a comparative analysis of KLPN1 with previously sequenced *Klebsiella* phages at the protein level ([@ref-1]). To improve genome annotations/predictions, all proteins encoded by ORFs in the genome sequence of KLPN1 were searched against InterProScan (<http://www.ebi.ac.uk/interpro/>). HHpred (<http://toolkit.tuebingen.mpg.de/hhpred>) searches were done to identify domains associated with depolymerase activity.

Screening virome datasets for phage sequences related to KLPN1
--------------------------------------------------------------

Fasta files associated with public virome datasets were downloaded from the METAVIR web server (<http://metavir-meb.univ-bpclermont.fr>; [@ref-45]) on 31 March 2015 ([Table S1](#supp-1){ref-type="supplementary-material"}). Each fasta file was used to create a BLAST database, against which the genome sequence of phage KLPN1 was searched using BLASTN.

Results
=======

Isolation and characterization of bacteria isolated from caecal effluent
------------------------------------------------------------------------

On fastidious anaerobe agar, 2.22 × 10^8^ ± 5.30 × 10^7^ (*n* = 3 replica plating) bacteria were isolated per millilitre of caecal effluent sample (log~10~ 8.35 ± 7.72 bacteria/ml caecal effluent). Ten colonies were randomly selected from one of the triplicate plates used to enumerate the bacteria, and streaked to purity. On the basis of 16S rRNA gene sequence analysis (EzTaxon), isolates represented *Klebsiella pneumoniae* (*n* = 5), *Bacteroides vulgatus* (*n* = 2), *Bacteroides massiliensis* (*n* = 1), a novel member of the order *Erysipelotrichales* distantly related to \[*Clostridium*\] *innocuum* (*n* = 1), and *Haemophilus parainfluenzae* (*n* = 1).

It is widely accepted that identification of members of the family *Enterobacteriaceae* is difficult on the basis of 16S rRNA gene sequence data alone; therefore, one of the strains identified as *K. pneumoniae*, L4-FAA5, was characterized using the PCR-based methods of [@ref-52]. The isolate was found to be a strain of *K. pneumoniae* subsp. *pneumoniae*, capsular type K2, *rmpA*^+^. Its VNTR profile was unique among the clinical isolates tested and on the wider database of clinical isolates held by Public Health England--Colindale.

Screening of filter-sterilized caecal effluent against bacteria to isolate phages
---------------------------------------------------------------------------------

The *K. pneumoniae* isolates were used in spot assays with the caecum filtrate, which was free of bacteria (as verified by Gram-stained smear and plating on nutrient agar; not shown). Phages infecting these isolates were initially identified in the caecal effluent by spotting 10 µl aliquots of filtered caecal effluent onto TSA overlays containing 200 µl of a given culture in the exponential phase of growth. Plaques identical to those shown in [Fig. 1A](#fig-1){ref-type="fig"} were observed with all *K. pneumoniae* isolates in the spot assays, and phages were present at 2 × 10^5^ ± 2.65 × 10^3^ (*n* = 3) pfu/ml caecal effluent. Clear plaques of 2 mm diameter were visible within 3 h of spotting onto an agar overlay. After prolonged incubation, the area around the plaques developed opaque haloes presumably caused by depolymerase activity, which increased in size over the course of 4 days, although the central clear area of the plaques remained 2 mm in diameter ([Fig. 1B](#fig-1){ref-type="fig"}). This phenomenon has been observed previously for lytic phages of the families *Siphoviridae*, *Podoviridae* and *Myoviridae* against *K. pneumoniae*, and is associated with degradation of capsular polysaccharides ([@ref-15]; [@ref-55]; [@ref-18]; [@ref-29]; [@ref-48]). The non-*Klebsiella* isolates were not screened against the caecum filtrate for phages.

![Appearance of plaques formed on *K. pneumoniae* subsp. *pneumoniae* L4-FAA5 by phage KLPN1.\
(A) Initial isolation of phages from filtered caecal effluent on TSA. (B) Appearance of plaques of pure phage stock after 24 h. (C) Growth of haloes surrounding plaques over the course of the course of 96 h. After 48 h, presumed phage-insensitive mutants can be seen growing in the haloes surrounding the plaques. Images are shown to scale.](peerj-03-1061-g001){#fig-1}

Strain L4-FAA5 was used as the host bacterium on which to isolate and propagate one phage (which we named KLPN1) to purity. KLPN1 infected all *K. pneumoniae* isolates recovered from the filter-sterilized caecal effluent.

The ability of phage KLPN1 to infect a panel of *K. pneumoniae* subsp. *pneumoniae* clinical isolates was determined ([Table 1](#table-1){ref-type="table"}), which revealed that all K2 strains tested (including the type strain) were sensitive to this phage, though KLPN1 did not infect any of the other tested strains belonging to other capsular types. VNTR analysis showed that the six K2 isolates in the panel represented five, distinct strains, suggesting a wide susceptibility to the phage among isolates of this capsular type. In addition, it did not exhibit depolymerase activity with any of the clinical K2 isolates.

Characterization of phage KLPN1
-------------------------------

Phage KLPN1 is chloroform-resistant. In addition, it displayed stability to prolonged storage in TSB at 4 °C: after 6 and 18 months' storage, titres for the phage were still 10^10^ pfu/ml, comparable with the original stock. Transmission electron microscopy revealed the isometric-headed phage to possess a capsid of ∼62.7 ± 2.3 nm (*n* = 30) in diameter with a long non-contractile tail of ∼164.4 ± 3.0 nm (*n* = 29), thus indicating that this phage is a member of the family *Siphoviridae* ([Fig. 2](#fig-2){ref-type="fig"}). Notably, the base-plate structure was unusual with a distinct central tail fibre \[length 33.4 ± 1.7 nm (*n* = 43)\] with apparently three elongated spherical structures \[length, 13.2 ± 1.3 nm (*n* = 43); width, 6.9 ± 0.7 nm (*n* = 48)\] loosely associated with the central regions of the tail fibre. This unique base-plate structures resembles a rosette with three leaves, and can be observed in all five micrographs shown in [Fig. 2](#fig-2){ref-type="fig"}. A similar structure has been described for Rtp, a lytic phage of *Escherichia coli* ([@ref-59]), with which KLPN1 shares some sequence identity (discussed below). It is also visible in electron micrographs of phage *ϕ*28, which infects *K. pneumoniae* capsular type K28 ([@ref-15]).

![Transmission electron micrographs of phage KLPN1.\
The phage belongs to the family *Siphoviridae*, and has an unusual base-plate structure, resembling a rosette. The arrows indicate the central tail fibre surrounded by three flexible spherical base-plate structures.](peerj-03-1061-g002){#fig-2}

It was straightforward to isolate high-quality DNA from phage KLPN1. Heating an aliquot of CsCl-purified, DNAse-/RNAse-treated sample at 80 °C for 10 min followed by phenol/chloroform/isoamyl alcohol extractions and ethanol precipitation gave large quantities of high-quality DNA that was used for restriction digests (not shown) and genome sequencing. The estimated genome size of KLPN1 based on restriction digests with EcoRV or HaeIII was ∼45 kbp, which was an underestimation of the genome size of 49,037 bp as determined by sequencing (see below).

Sequence analysis of KLPN1
--------------------------

The genome of KLPN1 was 49,037 bp with a G + C content of 50.53%, similar to previously sequenced *Klebsiella Siphoviridae* phages such as KP36 ([Table 2](#table-2){ref-type="table"}). Initial genome annotation was performed using Genemark ([@ref-2]), from which a gff file was generated to allow visualisation of the predicted ORFs in Artemis v10.0 ([@ref-46]). Each ORF with a minimum amino acid content of 30, a start and stop codon as well as a ribosomal-binding site was retained ([Table 3](#table-3){ref-type="table"}). The genome of KLPN1 was predicted to encompass 73 ORFs divided into four clusters, two rightward and two leftward ([Fig. 3](#fig-3){ref-type="fig"}, [Table 3](#table-3){ref-type="table"}). Of the 73 predicted ORFs, 23 were assigned a function with the remainder representing hypothetical proteins with no assignable function ([Table 3](#table-3){ref-type="table"}). BLAST analysis of the complete nucleotide sequence indicated that KLPN1 is closely related to the *Klebsiella* phages KP36 (95% identity across 86% of the genome; [@ref-22]), F20 (84% identity across 82% of the genome, GenBank accession no. [JN672684](JN672684); [@ref-36]) and phage 1513 (95% identity across 85% of the genome, GenBank accession no. [KP658157](KP658157); [@ref-7]). Furthermore, partial identity was observed against *Shigella* phage Shfl1 as well as enterobacterial phages T1 ([@ref-44]) and RTP ([@ref-59]) (GenBank accession numbers [HM035024](HM035024), [AY216660](AY216660) and [AM156909](AM156909), respectively). A comparative analysis of KLPN1 was performed against both known members (KP36, F20) of the genus "Kp36likevirus" ([@ref-37]; [Table 3](#table-3){ref-type="table"}, [Fig. 3](#fig-3){ref-type="fig"}). For completion, KLPN1 was also compared with previously sequenced *Klebsiella* phages ([Table 2](#table-2){ref-type="table"}). KLPN1 was shown not to share detectable homology with *Klebsiella* phages belonging to the family *Podoviridae* or *Myoviridae*. Based on the amino acid percentage identities presented in [Table 3](#table-3){ref-type="table"}, the genomes of KLPN1 and related phages were divided into functional conserved modules: packaging, phage particle morphogenesis and DNA replication ([Fig. 3](#fig-3){ref-type="fig"}, [Table 3](#table-3){ref-type="table"}). Sections of the KLPN1 genome were shown to exhibit homology to the *Siphoviridae* phage phiKO2 genome, although such homology was confined to the tail morphogenesis region and one hypothetical protein ([Table 3](#table-3){ref-type="table"}). Of the 73 predicted ORFs, only three appeared unique to KLPN1: two genes encoding hypothetical proteins located at the 5' end of the genome and a putative homing endonuclease-gene positioned in the capsid morphogenesis module ([Table 3](#table-3){ref-type="table"}).

![Genome structures of the four members of the genus "Kp36likevirus".\
Phages KLPN1, KP36 and 1513 are virulent to *K. pneumoniae*, while F20 is virulent to *Enterobacter aerogenes* ([@ref-36]).](peerj-03-1061-g003){#fig-3}
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###### Characteristics of previously sequenced *Klebsiella* phages.
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  Phage             Family           Size (bp)   G+C(%)   No. of predicted ORFs   GenBank accession no.    Reference
  ----------------- ---------------- ----------- -------- ----------------------- ------------------------ ------------
  NTUH-K2044-K1-1   *Podoviridae*    43,871      54.2     35                      [NC_025418](NC_025418)   [@ref-29]
  F19               *Podoviridae*    43,766      53.8     51                      [NC_023567](NC_023567)   --
  K11               *Podoviridae*    41,181      53.2     51                      [NC_011043](NC_011043)   --
  KP34              *Podoviridae*    43,809      54.1     57                      [NC_013649](NC_013649)   [@ref-12]
  KP32              *Podoviridae*    41,119      52.4     44                      [NC_013647](NC_013647)   [@ref-22]
  P13               *Podoviridae*    45,976      51.7     50                      --                       [@ref-48]
  0507-KN2-1        *Myoviridae*     159,991     46.7     154                     [NC_022343](NC_022343)   [@ref-18]
  JD001             *Myoviridae*     48,814      48.5     68                      [NC_020204](NC_020204)   [@ref-11]
  KP27              *Myoviridae*     174,413     41.8     276                     [NC_020080](NC_020080)   [@ref-22]
  KP15              *Myoviridae*     174,436     41.8     258                     [NC_014036](NC_014036)   [@ref-22]
  vB_KleM-RaK2      *Myoviridae*     345,809     32       534                     [NC_019526](NC_019526)   [@ref-50]
  K64-1             *Myoviridae*     346,602     31.72    64                      [AB897757](AB897757)     [@ref-39]
  KP36              *Siphoviridae*   49,820      50.7     80                      [NC_019781](NC_019781)   [@ref-22]
  phiKO2            *Siphoviridae*   51,601      51.5     64                      [NC_005857](NC_005857)   [@ref-8]
  1513              *Siphoviridae*   49,462      50.61    72                      [KP658157](KP658157)     [@ref-7]
  KLPN1             *Siphoviridae*   49,037      50.5     73                      [KR262148](KR262148)     This study
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###### Genomic structure of phage KLPN1.

![](peerj-03-1061-g007)

  KLPN1 genome   Start   Stop    Ribosome-binding site   Start   Strand   Predicted product[^\*^](#table-3fn1){ref-type="fn"}                                                                  Representative ORF in phage (% amino acid identity)                                       
  -------------- ------- ------- ----------------------- ------- -------- -------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- --------------------- ------------- ------------
  KLPN1_01       516     1079    AAGGAG                  ATG     \+       Unknown                                                                                                              --                                                    --                    --            --
  KLPN1_02       1069    1290    AGGAGG                  ATG     \+       HP                                                                                                                   --                                                    --                    --            --
  KLPN1_03       1395    1547    GAGGAA                  ATG     \+       HP pSf1_0028 (*Shigella* phage pSf-1)                                                                                --                                                    --                    39 (94)       --
  KLPN1_04       1752    1997    GAAGAtAG                TTG     \+       HP (*Escherichia* phage e4/1c)                                                                                       --                                                    --                    38 (98.36)    --
  KLPN1_05       2186    2416    AGGAGGA                 ATG     \+       HP KP36_04 KP36                                                                                                      04 (74.65)                                            76 (63.38)            37 (92.11)    --
  KLPN1_06       2487    2699    AGAGGA                  ATG     \+       HP KP36_06 KP36                                                                                                      06 (82.86)                                            --                    36 (90)       --
  KLPN1_07       2710    3030    AAGGAGAA                ATG     \+       HP KP36_11 KP36                                                                                                      11 (78.3)                                             70 (65.09)            35 (82.08)    --
  KLPN1_08       3100    3471    GGAGA                   ATG     \+       HP (Enterobacteria phage F20)                                                                                        --                                                    69 (83.74)            --            --
  KLPN1_09       3481    3783    GAGGtGGccG              ATG     \+       HP KP36_15 KP36                                                                                                      15 (91)                                               68 (56)               33 (85)       --
  KLPN1_10       3783    4028    AAcGGGA                 ATG     \+       HP KP36_16 KP36                                                                                                      16 (97.53)                                            67 (83.95)            32 (92.59)    --
  KLPN1_11       4025    4210    GAGGtAAAAG              ATG     \+       HP KP36_17 KP36 [(signal peptide)]{.ul}                                                                              17 (85.25)                                            66 (78.69)            31 (58.18)    --
  KLPN1_12       4291    4500    AAtcAGGAG               ATG     \+       HP (Enterobacteria phage F20)                                                                                        --                                                    65 (73.91)            --            --
  KLPN1_13       4500    4934    GAGGAGA                 ATG     \+       HP (Enterobacteria phage F20)                                                                                        19 (33.93)                                            64 (32.54)            29 (35.58)    --
  KLPN1_14       5004    5750    AAGAGGAA                ATG     \+       HP (Enterobacteria phage F20)                                                                                        20 (50.94)                                            63 (54.55)            28 (34.84)    --
  KLPN1_15       5827    6099    AGGAG                   ATG     \+       HP KP36_22 KP36                                                                                                      22 (65.56)                                            61 (66.67)            --            --
  KLPN1_16       6096    6668    AAGGtGAtcGAA            ATG     \+       HP KP36_23 KP36                                                                                                      23 (96.32)                                            60 (78.53)            25 (76.44)    --
  KLPN1_17       6738    6974    AAGGAG                  ATG     \+       HP KP36_24 KP36                                                                                                      24 (92.31)                                            59a (86.3)            24 (96.15)    --
  KLPN1_18       6962    7195    GGAGAAGG                ATG     \+       HP KP36_25 KP36                                                                                                      25 (100)                                              59 (87.01)            23 (95.45)    --
  KLPN1_19       7324    7518    AAAGGG                  ATG     \+       HP KP36_26 KP36                                                                                                      26 (96.67)                                            57 (93.65)            22 (96.88)    --
  KLPN1_20       7512    7718    AAGGGAA                 ATG     \+       HP KP36_27 KP36 [(signal peptide)]{.ul}                                                                              27 (96.2)                                             56 (64.81)            21 (100)      --
  KLPN1_21       7773    8378    GAAGcGGcGtAA            ATG     \+       terminase small subunit KP36                                                                                         28(92.53)                                             55 (91.95)            20 (90.8)     --
  KLPN1_22       8388    9992    AAGGGccGA               ATG     \+       terminase large subunit KP36 [(terminase-like family: PF03237)]{.ul}                                                 29 (99.25)                                            54 (98.13)            19 (99.44)    --
  KLPN1_23       10038   11348   AAAcAAGGttGA            ATG     \+       portal protein KP36 [(phage portal protein, SPP1 Gp6-like: PF05133)]{.ul}                                            30 (98.62)                                            53 (91.78)            18 (99.31)    --
  KLPN1_24       11335   12102   GGAGGcGGA               ATG     \+       capsid morphogenesis protein KP36 [(phage head morphogenesis domain: IPR006528)]{.ul}                                31 (96.44)                                            52 (90.12)            17 (95.22)    --
  KLPN1_25       12104   12589   GAGGttAG                ATG     \+       HP gp40 (*Escherichia* phage phiEB49) HNH endonuclease [(HNH endonuclease: PF13392)]{.ul}                            --                                                    --                    --            --
  KLPN1_26       12586   13716   GGAGA                   ATG     \+       capsid protein KP36                                                                                                  32 (99.47)                                            51 (93.09)            16 (99.47)    --
  KLPN1_27       13768   14286   AGGAGA                  ATG     \+       HP KP36_33 KP36                                                                                                      33 (96.2)                                             50 (50.87)            15 (96.84)    --
  KLPN1_28       14400   15359   AGGAG                   ATG     \+       major capsid protein KP36_34 KP36                                                                                    34 (98.75)                                            49 (94.36)            14 (98.43)    --
  KLPN1_29       15451   15756   GGAGcA                  ATG     \+       HP KP36_35 KP36                                                                                                      35 (100)                                              48 (86.15)            13 (98.77)    --
  KLPN1_30       15753   16226   AAAAGcGcGGA             ATG     \+       HP KP36_36 KP36                                                                                                      36 (100)                                              47 (92.75)            12 (97.83)    --
  KLPN1_31       16232   16609   GGtAGGtGA               ATG     \+       HP KP36_37 KP36                                                                                                      37 (99.2)                                             46 (94.4)             11 (98.4)     --
  KLPN1_32       16602   17039   AGGGtGGcGA              ATG     \+       HP KP36_38 KP36                                                                                                      38 (100)                                              45 (92.41)            10 (99.05)    --
  KLPN1_33       17029   17463   GAGcGAGG                ATG     \+       HP (Enterobacteria phage F20) Tail protein [(phage tail protein: PF13554)]{.ul}                                      39 (76.39)                                            44 (88.19)            09 (74.19)    --
  KLPN1_34       17450   18136   GGAGGcGA                ATG     \+       HP (Enterobacteria phage F20) Tail protein [(phage tail protein: PF08813)]{.ul}                                      --                                                    43/42 (68.26/42.04)   08 (43.36)    --
  KLPN1_35       18189   18845   AGGAG                   ATG     \+       HP (Enterobacteria phage F20) Tail protein [(phage tail protein: PF08813)]{.ul}                                      40 (91.67)                                            42 (82.87)            08 (96.33)    --
  KLPN1_36       18922   19248   AGGAG                   ATG     \+       Tape measure chaperone protein [(domain of unknown function DUF1789: PF08748)]{.ul}                                  41 (98.15)                                            41 (57.01)            07 (98.15)    --
  KLPN1_36.1     19239   19562   --                      --      \+       Tape measure chaperone protein [(phage-related hypothetical protein DUF1799: PF08809)]{.ul}                          --                                                    40 (92.73)            06 (96.36)    --
  KLPN1_38       19620   22565   GAtAAAGtAG              TTG     \+       tail length tape-measure protein KP36 [(*λ* phage tail tape-measure protein: PF09718)]{.ul}                          43 (91.63)                                            39 (80.22/68.85)      05 (91.04)    --
  KLPN1_39       22568   22912   AAcGAGGG                GTG     \+       minor tail protein KP36 [(minor tail protein: PF05939)]{.ul}                                                         44 (88.6)                                             38 (87.72)            04 (86.84)    16 (28.32)
  KLPN1_40       22949   23734   --                              \+       minor tail protein KP36 [(minor tail protein L: TIGR01600)]{.ul}                                                     45 (93.17)                                            37 (91.27)            03 (92.77)    17 (36.78)
  KLPN1_41       23736   24473   GAAAAGcGGAcGG           ATG     \+       minor tail protein KP36 [(endopeptidase, NlpC/P60 family: PF00877)]{.ul}                                             46 (93.47)                                            36 (96.33)            02 (94.69)    18 (42.62)
  KLPN1_42       24448   25050   AAGGA                   ATG     \+       tail assembly protein KP36 [(*λ* tail assembly protein I: PF06805)]{.ul}                                             47 (94.5)                                             35 (98)               01 (95.03)    --
  KLPN1_43       25138   28839   AGGAGG                  ATG     \+       tail fiber protein KP36 [(putative phage tail protein: PF13550)]{.ul}                                                48 (95.86)                                            34 (88.6)             01a (95.06)   21 (39.75)
  KLPN1_44       29027   31297   AAGAGG                  ATG     --       HP L418_01651 (*Klebsiellapneumoniae* UCICRE 7) [(galactose-binding domain-like: IPR008979)]{.ul}                    49 (66.79)                                            32 (83.49)            71 (70.15)    --
  KLPN1_45       31392   31853   AGGAAcGA                ATG     --       single-stranded DNA binding protein KP36 [(nucleic-acid binding proteins: SSF50249)]{.ul}                            50 (98.04)                                            31 (82.35)            70 (96.08)    --
  KLPN1_46       31890   32546   AAGGAAA                 ATG     --       putative recombination protein KP36 [(signal peptide)]{.ul}                                                          51 (99.54)                                            30 (93.12)            69 (98.62)    --
  KLPN1_47       32606   33652   GGAGcAA                 ATG     --       exodeoxyribonuclease VIII KP36 [(PD-(D/E)XK nuclease superfamily: PF12705)]{.ul}                                     52 (97.7)                                             29 (93.39)            68 (97.99)    --
  KLPN1_48       34148   35107   GGAGGtAA                GTG     --       DNA primase KP36 [(bacteriophage T7, Gp4, DNA primase/helicase, N-terminal: IPR013237)]{.ul}                         53 (98.7)                                             28 (88.64)            67 (99.35)    --
  KLPN1_49       35183   35584   GAGGGttAA               ATG     --       putative transcriptional regulator KP36 [(*λ* repressor-like, DNA-binding domain: IPR010982)]{.ul}                   54 (98.5)                                             27 (95.49)            66 (99.25)    --
  KLPN1_50       35676   37712   AGGAttG                 ATG     \+       DNA helicase KP36 [(helicase, C-terminal: IPR001650)]{.ul}                                                           55 (98.52)                                            26 (94.25)            65 (98.82)    --
  KLPN1_51       37709   38116   GGAGGcGAGG              GTG     \+       HP KP36_56 KP36 [(VRR-NUC domain: IPR014883)]{.ul}                                                                   56 (99.08)                                            25 (86.61)            64 (100)      --
  KLPN1_52       38181   38468   GAAGAAcGGA              ATG     \+       HP KP36_57 KP36 [(signal peptide)]{.ul}                                                                              57 (95.65)                                            --                    63 (94.87)    --
  KLPN1_53       38471   39202   GcGAGGttAA              ATG     \+       DNA adenine methyltransferase KP36 [(phage *N*-6-adenine-methyltransferase: TIGR01712)]{.ul}                         58 (97.53)                                            23 (92.59)            62 (97.94)    --
  KLPN1_54       39204   39440   GcGtAtGcGAA             ATG     \+       HP KP36_59 KP36                                                                                                      59 (88.46)                                            22 (79.49)            61 (89.74)    --
  KLPN1_55       39451   39741   --                      ATG     \+       HP (Enterobacteria phage F20)                                                                                        60 (98.72)                                            21 (83.33)            60 (98.72)    --
  KLPN1_56       39741   39989   GGtGAcGA                ATG     \+       HP KP36_61 KP36                                                                                                      61 (95.18)                                            20 (89.02)            59 (96.39)    --
  KLPN1_57       40085   41215   AAttGGGAtAA             ATG     \+       HP KP36_62 KP36 [(metallo-dependent phosphatase-like: IPR029052)]{.ul}                                               62 (99.2)                                             19 (94.15)            58 (99.2)     --
  KLPN1_58       41254   41745   AAGGAAA                 ATG     \+       3'-phosphatase, 5'-polynucleotide kinase KP36 [(HAD superfamily, subfamily IIIB (acid phosphatase): PF03767)]{.ul}   63 (93.87)                                            18 (75.46)            57 (95.09)    --
  KLPN1_59       41742   42323   GGAGtAGA                ATG     \+       HP KP36_64 KP36 [(P-loop containing nucleoside triphosphate hydrolase: IPR027417)]{.ul}                              64 (99.48)                                            17 (88.17)            56 (99.48)    --
  KLPN1_60       42450   42665   AGAGG                   ATG     \+       holin KP36                                                                                                           65 (83.1)                                             16 (80.28)            55 (83.1)     --
  KLPN1_61       42667   43149   AGGAGcAAG               ATG     \+       endolysin KP36 [(lysozyme-like domain: IPR023346)]{.ul}                                                              66 (86.23)                                            15 (90.57)            54 (98.12)    --
  KLPN1_62       43146   43571   AAGGA                   ATG     \+       Rz1A protein KP36                                                                                                    67 (96.45)                                            14 (89.36)            53 (99.29)    --
  KLPN1_63       43641   44102   GAGGtAA                 ATG     --       HP KP36_68 KP36                                                                                                      68 (98.69)                                            13 (88.89)            52 (98.69)    --
  KLPN1_64       44106   45674   AGGAGcAAGG              ATG     --       HP KP36_69 KP36 [(protein of unknown function DUF3987: PF13148)]{.ul}                                                69 (99.81)                                            12 (95.79)            51 (99.81)    --
  KLPN1_65       45800   46237   GGAGAAAG                ATG     --       HP KP36_70 KP36                                                                                                      70 (97.93)                                            11 (91.03)            50 (98.62)    --
  KLPN1_66       46238   46420   GAAGAAA                 ATG     --       HP KP36_71 KP36                                                                                                      71 (93.33)                                            10 (86.44)            49 (93.33)    --
  KLPN1_67       46417   46620   GGAGtAAAcGGA            ATG     --       HP KP36_72 KP36                                                                                                      72 (97.01)                                            09 (65.67)            48 (92.54)    --
  KLPN1_68       46693   47385   AAAtGGtGGA              ATG     --       HP KP36_73 KP36                                                                                                      73 (97.83)                                            08 (90)               47 (96.96)    42 (56.83)
  KLPN1_69       47382   47681   GGcAtAG                 TTG     --       HP KP36_74 KP36                                                                                                      74 (100)                                              06 (55.41)            46 (52.7)     --
  KLPN1_70       47688   48065   GAAAcGAGG               ATG     --       HP KP36_75 KP36                                                                                                      75 (96)                                               05 (66.13)            45 (70)       --
  KLPN1_71       48065   48304   GAGAAGGG                ATG     --       HP KP36_76 KP36                                                                                                      76 (96.2)                                             04 (93.1)             44 (97.47)    --
  KLPN1_72       48301   48495   AGGAGAA                 ATG     --       HP KP36_77 KP36                                                                                                      77 (93.75)                                            03 (84.81)            43 (95.31)    --
  KLPN1_73       48568   48849   AGAGGG                  ATG     --       HP KP36_78 KP36                                                                                                      78 (97.47)                                            02 (84.81)            42 (96.2)     --

**Notes.**

HP, hypothetical protein. Underlined predicted products are from InterProScan (<http://www.ebi.ac.uk/interpro/>) searches that returned results with the amino acid sequence encoded by each ORF ([Table S2](#supp-1){ref-type="supplementary-material"}).

Based on sequence homology to ORF33 (encoding the host-specificity J protein; InterPro IPR021034) of phage T1, the phage receptor-binding protein of KLPN1 was predicted to be encoded by ORF43. The deduced ORF43 protein was found to exhibit similarity to fibronectin type III domain-containing protein, and potentially encodes the depolymerase whose effect was observed on the phage assay plates ([Fig. 1](#fig-1){ref-type="fig"}). However, a HHpred search with the protein sequence encoded by this ORF failed to detect any domains associated with enzymes (such as glycanases, deacetylases and lyases) associated with depolymerase activity of *Klebsiella* lytic phages ([@ref-15]). The protein encoded by ORF34 of phage NTUH-K2044-K1-1 has proven depolymerase activity associated with pectate lyase ([@ref-29]); a HHpred search confirmed the protein encoded by this ORF has a lyase/polygalacturonase domain (1ru4_A pectate lyase, 94.3% probability of true positive, E-value 0.055, P-value 1.6 × 10^−6^; 1bhe_A PEHA, polygalacturonase, 90.1% probability of true positive, E-value 13, P-value 0.00038). ORF96 of phage 0507-KN2-1 also encodes proven depolymerase activity ([@ref-18]). A HHpred search demonstrated the protein encoded by this ORF has an acetylneuraminidase domain (3gw6_A endo-*N*-acetylneuraminidase, 99.8% probability of true positive, E-value 1 × 10^−19^, P-value 2.9 × 10^−24^). The whole-genome sequence of phage P13 cannot be retrieved from GenBank; however, on the basis of a PSI-BLAST search conducted by [@ref-48], genes 49 and 50 of phage P13 are predicted to encode the exopolysaccharide depolymerase, but no further substrate/functional information is available. HHpred searches of all proteins encoded by KLPN1 showed that ORF34 and ORF35 encode an endo-*N*-acetylneuraminidase/endosialidase domain ([Table 4](#table-4){ref-type="table"}). Consequently, we predict ORF34 and/or ORF35 encode the depolymerase activity of phage KLPN1. Further work will be required to confirm our hypothesis.

10.7717/peerj.1061/table-4

###### Selected HHpred results for ORF34 and ORF35 of phage KLPN1.

![](peerj-03-1061-g008)

  Hit                                                                                                                                                                                   Probability of true positive   E-value         P-value         Score   SS    Cols   ORF amino acids   Reference
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ --------------- --------------- ------- ----- ------ ----------------- -------------
  **ORF34**                                                                                                                                                                                                                                                                                   
  2k4q_A Major tail protein V; GPV, bacteriophage lambda, viral protein; NMR {Enterobacteria phage lambda}                                                                              99.9                           1.3 × 10^−27^   3.6 × 10^−32^   195.4   7.6   124    99-224            [@ref-40]
  3ju4_A Endo-*N*-acetylneuraminidase; endonf, polysia, high-resolution, glycosidase, hydrolase; HET: SLB; 0.98A {Enterobacteria phage K1F}                                             81.6                           1.4             4.1 × 10^−5^    42.0    4.1   93     23-123            [@ref-47]
  4hiz_A Endosialidase, PHI92_GP143; sialidase fold, beta-helix, endo-alpha2,8-sialidase, endo-Al sialidase sialic acid polymer; HET: SLB SIA SUC; 1.60A {Enterobacteria phage PHI92}   80.9                           4               0.00012         39.1    6.8   65     23-95             Unpublished
  **ORF35**                                                                                                                                                                                                                                                                                   
  2k4q_A Major tail protein V; GPV, bacteriophage lambda, viral protein; NMR {Enterobacteria phage lambda}                                                                              99.9                           5.3 × 10^−28^   1.5 × 10^−32^   195.1   8.6   119    94-214            [@ref-40]
  4hiz_A Endosialidase, PHI92_GP143; sialidase fold, beta-helix, endo-alpha2,8-sialidase, endo-Al sialidase sialic acid polymer; HET: SLB SIA SUC; 1.60A {Enterobacteria phage PHI92}   91.4                           0.55            1.6 × 10^−5^    44.1    7.3   65     23-87             Unpublished
  3ju4_A Endo-*N*-acetylneuraminidase; endonf, polysia, high-resolution, glycosidase, hydrolase; HET: SLB; 0.98A {Enterobacteria phage K1F}                                             90.0                           0.59            1.7 × 10^−5^    43.8    6.2   65     23-87             [@ref-47]

The proteins encoded by ORF36 and ORF36.1 are predicted to be two chaperones, analogous to gpG and gpGT required for phage *λ* tail assembly ([@ref-60]). These ORFs are believed to keep the tail tape measure protein (TMP) soluble and to recruit the major tail protein subunits, both essential processes for tail assembly. ORF36 encodes the short chaperone (gpG), while a programmed -1 translational frameshift facilitates a translational fusion between the products of ORF36 and ORF36.1 so as to form the long chaperone (gpGT) (hence the lack of a ribosome-binding site for ORF36.1) ([Fig. 4](#fig-4){ref-type="fig"}). A BLASTP search of the predicted 213 aa fusion protein showed it shares 47% identity (E-value 3 × 10^−56^) with the tape measure chaperone of the *Citrobacter Siphoviridae* phage Stevie, reported to have a conserved translational frameshift ([@ref-49]; [Fig. 4](#fig-4){ref-type="fig"}).

![ORF36 and ORF36.1 are related by a programmed-1 translational frameshift.\
The frameshift allows translation of a gpGT-like protein ([@ref-60]). The ORF36/ORF36.1 fusion protein is predicted to contain almost the entire sequence of ORF36. *Citrobacter Siphoviridae* phage Stevie (GenBank accession number [KM236241](KM236241)) has a conserved translational frameshift in its tape measure chaperone (GenBank accession number [AIX12284](AIX12284)) ([@ref-49]).](peerj-03-1061-g004){#fig-4}

The genome sequence of KLPN1 was subjected to BLASTN searches against all publicly available virome sequence data held by METAVIR (51,992,208 sequence reads associated with 70 projects from a range of habitats, including human faeces ([@ref-42]; [@ref-23]; [@ref-35]; [@ref-34]); [Table S1](#supp-1){ref-type="supplementary-material"}). No hits corresponding to KLPN1 were found among these publicly available datasets. However, using InterProScan, the protein sequence encoded by ORF64 was found to belong to the family 'Protein of unknown function DUF3987', representing uncharacterized human-gut-microbiome-specific proteins ([@ref-13]; [Table 3](#table-3){ref-type="table"}).

Discussion
==========

*K. pneumoniae* subsp. *pneumoniae* is an enteric bacterium and important nosocomial and community-acquired opportunistic pathogen, causing pneumonia, and wound, burn, urinary tract and blood infections. There are 79 recognized capsular types of *K. pneumoniae* subsp. *pneumoniae*, with capsular types K1, K2, K5, K54 and K57 most frequently associated with invasive disease or pathogenicity; capsular type K20 is much rarer, though there is regional variability in the predominant clinically relevant capsular types ([@ref-52]; [@ref-38]; [@ref-18]). It has been suggested that the majority of *K. pneumoniae*-associated liver infections are preceded by colonization of the gastrointestinal tract, and one study has demonstrated familial spread of a virulent clone of *K. pneumoniae* causing liver disease ([@ref-16]; [@ref-30]). Using caecal effluent recovered from a healthy woman, we have isolated a capsular type K2 *rmpA*^+^ strain (L4-FAA5) of *K. pneumoniae* subsp. *pneumoniae*. After K1, K2 strains are most frequently associated with pyogenic liver abscesses and frequently associated with community-acquired pneumonia ([@ref-28]). K1 and K2 strains, along with the *rmpA* (regulator of mucoid phenotype A) gene, are associated with hypermucoviscosity and virulence. A study examining K1 and K2 strains of *K. pneumoniae* in 43 Taiwanese patients with liver abscesses showed, using pulsed-field gel electrophoresis (PFGE), that 17 randomly selected pairs of patient faecal or saliva and abscess isolates allowed differentiation of patients based on the PFGE profiles of their isolates. The abscess isolates had PFGE profiles identical, or closely related to, those of faecal or saliva isolates from the same patient ([@ref-14]). The similarity between each patient's faecal and abscess PFGE profiles led [@ref-14] to suggest that the patients' infections arose from bacteria originating in the gut microbiota. Our isolation of a *K. pneumoniae* strain with virulence traits from the human caecum supports the assertion that the human gut microbiota is a source of potentially infectious *K. pneumoniae*. Limited data are available on the carriage and diversity of gut/faecal *K. pneumoniae*. A study on healthy Chinese adults in Chinese territories and overseas showed between 18.8 and 87.7% faecal carriage of *K. pneumoniae*, with individuals in Malaysia (64/73) and Taiwan (150/200) showing the highest carriage rates and those in Japan (6/32) showing the lowest ([@ref-30]). Isolates were tested with antisera for capsular types K1--K74 and K80--82: K1 and K2 isolates accounted for ∼10% of isolates in all countries, at least one representative of each capsular type was detected in the study and non-typable (11--88%) isolates were reported for 7/8 countries ([@ref-30]). The high carriage of *K. pneumoniae* in Taiwan is thought to contribute to the high incidence of liver abscess disease seen in the country ([@ref-14]).

As with other nosocomial opportunistic pathogens, broad-spectrum antibiotic resistance is a feature of *K. pneumoniae* subsp. *pneumoniae* and limits treatment options ([@ref-6]). Therefore, identification of alternative treatment therapies or adjuncts to existing therapies for infections associated with this organism is of utmost importance. Phages against *K. pneumoniae* subsp. *pneumoniae* have been used to successfully treat *K. pneumoniae* infections in animal models of sepsis, pneumonia, burn wounds and liver disease, without causing apparent harm to animals ([@ref-3]; [@ref-32]; [@ref-9]; [@ref-24]; [@ref-26]; [@ref-19]). The number of known lytic phages that infect *K. pneumoniae* remains small and their range is limited to a small number of capsular types (though phenotypic information on strains is absent from the majority of publications on *K. pneumoniae* phages). Given the large number of phages present in faeces and caecal effluent ([@ref-17]), and because *K. pneumoniae* subsp. *pneumoniae* is a member of the human gut microbiota, we were keen to exploit this environment as a source of phages with potential therapeutic applications. We isolated from caecal effluent a phage (named KLPN1) that infects *K. pneumoniae* subsp. *pneumoniae* L4-FAA5 and K2 clinical isolates of *K. pneumoniae* subsp. *pneumoniae* ([Table 1](#table-1){ref-type="table"}). Phage KLPN1 does not infect non-K2 clinical isolates ([Table 1](#table-1){ref-type="table"}). To the best of our knowledge, this is the first report of the isolation of a bacterium--phage combination from the human caecum.

To date, only eight phages infecting the K2 capsular type of *K. pneumoniae* have been reported ([@ref-3]; [@ref-32]; [@ref-26]; [@ref-19]). Several *Podoviridae* were isolated on *K. pneumoniae* B5055 (assumed to be derived from NCTC 5055) and tested as therapeutic agents \[Kpn5, Kpn12, Kpn13, Kpn17, Kpn22 (individually and in cocktail) and KØ1\] in B5055-induced burn-wound infections in mice ([@ref-24]; [@ref-25]; [@ref-26]; [@ref-32]). Phage SS (*Podoviridae*) was isolated on B5055 and used to treat lobar pneumonia caused by the same strain in mice ([@ref-9]). Phage *ϕ*NK5 (*Podoviridae*) was isolated from sewage on *K. pneumoniae* NK-5, isolated from a patient with a primary liver abscess and septicaemia ([@ref-19]). The same bacterial strain was used to induce liver abscesses and bacteraemia in mice, which were successfully treated with *ϕ*NK5. None of the aforementioned phages has been tested against a range of clinical *K. pneumoniae* isolates. Therefore, it is difficult to assess how useful they would be in treatment of a wide range of clinical infections, especially when similar infections can be caused by different capsular types of *K. pneumoniae* (e.g., [Table 1](#table-1){ref-type="table"}). We can state that KLPN1 has potential for treating K2-associated infections, but note that differences in lytic infection were observed between the caecal isolate and the clinical isolates: KLPN1 infected the caecal isolate and exhibited depolymerase activity that was absent with the clinical K2 isolates. Further investigations may reveal that its infection kinetics differ between K2 strains.

[@ref-19] demonstrated the generation of phage-insensitive mutants after 6 and 12 h co-cultures of NK-5/*ϕ* NK5, with these mutants lacking the hypermucoviscosity phenotype of NK-5. On solid media, phage-insensitive mutants of *K. pneumoniae* L4-FAA5 were routinely observed after 48 h incubation with phage KLPN1. Whether mutants are generated more quickly in liquid culture remains to be determined, as does the nature of the mutations that allow them to escape lytic infection with KLPN1. Does solid media act as a spatial refuge ([@ref-33]) for sensitive bacteria, delaying the appearance of insensitive mutants?

It is predicted that many members of the human gut microbiota are embedded in biofilms, and phages may contribute to cell lysis in these ecological niches ([@ref-33]). The microbiota of the human caecum resides in a highly mucoid biofilm ([@ref-41]). Phage KLPN1 exhibits depolymerase activity on *K. pneumoniae* L4-FAA5, which may facilitate the movement of the phage within the caecal biofilm. It has been demonstrated that phages can diffuse within biofilms, be immobilized, amplified and released after a lytic cycle in these environments. They may also potentially interact with their specific binding sites on bacteria, even in the absence of lytic activity ([@ref-33]). Further work is needed to understand interactions between *K. pneumoniae* L4-FAA5 and phage KLPN1 in single- and multi-strain biofilm systems, and to determine whether the "spatial refuge hypothesis" ([@ref-33]) holds for the caecal microbiota, preventing the extinction of all sensitive bacteria within the biofilm.

Following whole-genome sequencing and annotation, KLPN1 was found to encompass 73 ORFs and, based on its sequence homology to *Klebsiella* phages KP36 and F20, it is evident that KLPN1 is a member of the family *Siphoviridae*, subfamily *Tunavirinae*, and would become the third member of the genus "Kp36likevirus" ([@ref-37]). In addition, based on our sequence analyses phage 1513 (a *Siphoviridae* that infects a multidrug-resistant *K. pneumoniae* strain isolated from a patient with pneumonia; [@ref-7]) can also be added to this genus, bringing the total number of members to four. This classification would be consistent with the morphological appearance of KLPN1, which has a capsid of 64 nm as well as rosette-like or propeller tail tip, a finding also observed for phages *ϕ*28, T1 and RTP ([@ref-15]; [@ref-59]). Unsurprisingly, KLPN1 shares no sequence homology with *Klebsiella* phages belonging to the families *Myoviridae* or *Podoviridae*;  however, some similarities to *Siphoviridae* phage phiKO2 were observed, but these were confined to the tail morphogenesis region and a hypothetical protein. ORF60 and ORF61 are predicted to encode holin (which destroys the cytoplasmic membrane) and endolysin (which degrades peptidoglycan), respectively. These gene products have antibacterial properties that can be used in phage-associated therapies ([@ref-57]); therefore, further characterization of the proteins encoded by these ORFs is required.

Conclusions
===========

We isolated a *K. pneumoniae* subsp. *pneumoniae*--phage combination from the human caecum, and have characterized its lytic properties against a panel of *K. pneumoniae* subsp. *pneumoniae* clinical isolates. Phage KLPN1 infects capsular type K2 isolates, and may have applications in treating a range of K2-associated infections. We have, therefore, demonstrated the gut microbiota as a source of clinically relevant phages. Whole-genome sequence analysis of KLPN1 revealed the phage to encode proteins that have potential applications in phage-associated therapies. Characterization of these gene products, or genetically modified variants, is required to determine their usefulness.
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